Deborah Wentworth

11.5k total citations · 4 hit papers
42 papers, 8.3k citations indexed

About

Deborah Wentworth is a scholar working on Epidemiology, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, Deborah Wentworth has authored 42 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Infectious Diseases and 8 papers in Economics and Econometrics. Recurrent topics in Deborah Wentworth's work include HIV/AIDS drug development and treatment (8 papers), Influenza Virus Research Studies (7 papers) and HIV Research and Treatment (7 papers). Deborah Wentworth is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Influenza Virus Research Studies (7 papers) and HIV Research and Treatment (7 papers). Deborah Wentworth collaborates with scholars based in United States, United Kingdom and Australia. Deborah Wentworth's co-authors include James D. Neaton, Jeremiah Stamler, Olga Vaccaro, Rose Stamler, David R. Jacobs, Jerome D. Cohen, Hiroyasu Iso, George Davey Smith, Lewis H. Kuller and Dan Garside and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Deborah Wentworth

42 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

1993 3.1k citations Jeremiah Stamler, Olga Vaccaro et al. Diabetes Care profile →
Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial

1989 844 citations Hiroyasu Iso, David R. Jacobs et al. New England Journal of Medicine profile →
Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy

1999 524 citations Jeremiah Stamler, Rose Stamler et al. JAMA profile →
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1986 438 citations Deborah Wentworth et al. PubMed profile →

Peers

Countries citing papers authored by Deborah Wentworth

Since Specialization

Citations

This map shows the geographic impact of Deborah Wentworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Wentworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Wentworth more than expected).

Fields of papers citing papers by Deborah Wentworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Wentworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Wentworth. The network helps show where Deborah Wentworth may publish in the future.

Co-authorship network of co-authors of Deborah Wentworth

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Wentworth. A scholar is included among the top collaborators of Deborah Wentworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Wentworth. Deborah Wentworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza 2023 ·JCI Insight ·Hillary A. Vanderven, Deborah Wentworth, Win Min Han, Heidi Peck, Ian Barr, Richard T. Davey, John H. Beigel, Dominic E. Dwyer, Mamta K. Jain, Brian Angus, Christian Brandt, Analía Mykietiuk, Matthew Law, James D. Neaton, Stephen J. Kent	5
2	Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies 2014 ·PLoS ONE ·Ruth Lynfield, Richard T. Davey, Dominic E. Dwyer, Marcelo Losso, Deborah Wentworth, Alessandro Cozzi‐Lepri, (unknown), (unknown), Daniel David, (unknown), (unknown), Timothy M. Uyeki, H. Clifford Lane, Jens Lundgren, James D. Neaton, (unknown)	26
3	Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus 2013 ·UCL Discovery (University College London) ·Kazima Saira, Xudong Lin, Jay V. DePasse, Rebecca Halpin, Alan Twaddle, Timothy B. Stockwell, Brian Angus, Alessandro Cozzi‐Lepri, Marina Delfino, Vivien G. Dugan, Dominic E. Dwyer, Matthew S. Freiberg, Andrzej Horban, Marcelo Losso, Ruth Lynfield, Deborah Wentworth, Edward C. Holmes, Richard T. Davey, David E. Wentworth, Elodie Ghedin	2
4	Predicting Adverse Events During Angiotensin Receptor Blocker Treatment in Heart Failure: Results from the HEAAL Trial 2012 ·European Journal of Heart Failure ·Michael S. Kiernan, Deborah Wentworth, Gary S. Francis, Felipe A. Martínez, Kenneth Dickstein, Michel Komajda, Faı̈ez Zannad, James D. Neaton, Marvin A. Konstam	25
5	Development and validation of a patient questionnaire to determine New York heart association classification 2004 ·Journal of Cardiac Failure ·Spencer H. Kubo, (unknown), Randall C. Starling, Mariell Jessup, Deborah Wentworth, Daniel Burkhoff	85
6	Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy 2002 ·AIDS ·John D. Baxter, Thomas C. Merigan, Deborah Wentworth, James D. Neaton, Marie L. Hoover, Richard M. W. Hoetelmans, Stephen C. Piscitelli, Werner Verbiest, Douglas L. Mayers	37
7	A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy 2000 ·AIDS ·John D. Baxter, Douglas L. Mayers, Deborah Wentworth, James D. Neaton, Marie L. Hoover, Mark A. Winters, Sharon Mannheimer, Melanie Thompson, Donald I. Abrams, Barbara Brizz, John P. A. Ioannidis, Thomas C. Merigan	379
8	Frequency of Antiretroviral Drug Resistance Mutations in HIV-1 Strains from Patients Failing Triple Drug Regimens 2000 ·Antiviral Therapy ·Mark A. Winters, John D. Baxter, Douglas L. Mayers, Deborah Wentworth, Marie L. Hoover, James D. Neaton, Thomas C. Merigan	28
9	Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy breakdown → 1999 ·JAMA ·Jeremiah Stamler, Rose Stamler, James D. Neaton, Deborah Wentworth, Martha L. Daviglus, Dan Garside, Alan R. Dyer, (unknown), Philip Greenland	524
10	Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: II. Black men. 1996 ·American Journal of Public Health ·George Davey Smith, Deborah Wentworth, James D. Neaton, Rose Stamler, Jeremiah Stamler	233
11	DATA ANALYSIS ISSUES FOR PROTOCOLS WITH OVERLAPPING ENROLLMENT 1996 ·Statistics in Medicine ·Kinley Larntz, James D. Neaton, Deborah Wentworth, (unknown)	16
12	Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial 1994 ·The Journal of Infectious Diseases ·Mark Z. Jacobson, C. Lynn Besch, Carroll Child, Richard Hafner, John P. Matts, K Muth, Deborah Wentworth, James D. Neaton, (unknown), David Rimland, George Perez, (unknown), Louis D. Saravolatz, Lawrence S. Brown, Lawrence Deyton	40
13	Considerations in choice of a clinical endpoint for AIDS clinical trials 1994 ·Statistics in Medicine ·James D. Neaton, Deborah Wentworth, Frank S. Rhame, (unknown), Donald I. Abrams, Lawrence Deyton	57
14	Risk factors for postthyroidectomy hypocalcemia. 1994 ·PubMed ·Christopher R. McHenry, Theodore Speroff, Deborah Wentworth, Thomas J. Murphy	160
15	Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial breakdown → 1993 ·Diabetes Care ·Jeremiah Stamler, Olga Vaccaro, James D. Neaton, Deborah Wentworth	3076
16	Influence of serum cholesterol, blood pressure, and cigarette smoking on death from coronary heart disease in 316,099 white men aged 35-57 years: Overall findings and differences by age 1992 ·JAMA Internal Medicine ·(unknown), Deborah Wentworth	13
17	Serum Cholesterol Concentration and Primary Malignant Brain Tumors: A Prospective Study 1992 ·American Journal of Epidemiology ·George Davey Smith, James D. Neaton, Yoav Ben‐Shlomo, Martin J. Shipley, Deborah Wentworth	12
18	An examination of the efficiency of some quality assurance methods commonly employed in clinical trials 1990 ·Statistics in Medicine ·James D. Neaton, Alain DuChêne, Kenneth H. Svendsen, Deborah Wentworth	47
19	The Epidemiology of Pulmonary Function and COPD Mortality in the Multiple Risk Factor Intervention Trial 1989 ·American Review of Respiratory Disease ·Lewis H. Kuller, Judith K. Ockene, Mary C. Townsend, Warren S. Browner, Elaine N. Meilahn, Deborah Wentworth	50
20	Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial breakdown → 1989 ·New England Journal of Medicine ·Hiroyasu Iso, David R. Jacobs, Deborah Wentworth, James D. Neaton, Jerome D. Cohen	844

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact